- Co. listed assets of more than $50m and debt of more than $100m in Chapter 11 documents filed Thursday in U.S. Bankruptcy Court in Rochester, New York
- During the past five years, the company has been named as a defendant in “numerous” state and federal litigation involving the sale of controlled substances, including opioids
- Co. has incurred over $1.6m in attorney’s fees and defense costs
- The cooperative, which was formed in 1905, was recently ranked as the sixth largest pharmaceutical distributor in the U.S., according to ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
